Define the customer and intended use.
Clarify who the product is for, the context it serves, and what it must never imply.
B2B longevity product development
The longevity label sells the idea. It doesn't define the customer, the intended use, or the evidence. Build that decision framework before formulation, partners, or scale lock the concept in.

The theme is compelling. It still doesn't tell you the customer, the intended use, the product category, the evidence you will need, or the lawful path to market.
The theme is compelling. It still doesn't tell you the customer, the intended use, the product category, the evidence you'll need, or the lawful path to market.
A longevity concept can land in supplements, consumer wellness, professional-use products, education, and more. Each category carries its own product, evidence, regulatory, and commercialization questions.
Launch Lab draws the decision map before the concept is committed to a formula, a platform, a vendor, or a market claim.
Clarify who the product is for, the context it serves, and what it must never imply.
Weigh format, product experience, feasibility, evidence expectations, and category constraints before you pick one.
Identify the language, evidence, and qualified-review questions before product and marketing decisions harden.
Connect pilot cost, partner model, price, channel, margin, and the criteria for scaling.
Trend-first route
The concept gets framed in longevity language first, then a formula, technology, or supplier is chosen to fill the gap.
Product-case route
Category, partners, pilot, claims guardrails, and economics are developed together, not bolted on afterward.
Demand, product, sample, and market decisions are developed together so a late-stage choice does not undo the work that came before it.
Define the customer, repeated need, channel advantage, target economics, and strategic reason the product should exist.
Translate the business case into a target product profile with format, experience, performance intent, differentiation, and constraints.
Evaluate samples against the brief, not against what happens to be easiest for a supplier to provide.
Connect the selected direction to pricing, positioning, partners, launch sequencing, proof, and decision gates.
The working set is designed for established founders, clinics, and health businesses evaluating a real product opportunity.
Customer, intended use, product category, commercial role, boundaries, and decision gates.
Format, experience, performance intent, evidence questions, cost targets, and constraints.
Questions for substantiation, testing, qualified review, and responsible communication.
What the pilot or sample must demonstrate before deeper investment.
Scientific, testing, quality, manufacturing, documentation, and commercialization partner requirements.
Pilot cost, target price, channel, contribution margin, volume, and scale thresholds.
Positioning, channel, proof, sequencing, launch milestones, and stop/revise criteria.
Relevant authority
B2B
The page is intentionally written around product and commercialization decisions, not age reversal, disease, treatment, or patient-outcome promises.
Evidence required before launch
Add product, pilot, partner, and market evidence after qualified review. Avoid sensitive-health audience targeting and unsupported longevity claims.
Dr. Maryam Alavi has worked across research, regenerative medicine, R&D, manufacturing, sales, business development, and commercialization. That breadth helps keep the product brief, sample decisions, economics, and market plan connected.

Why the operating range matters
A product can be perfectly feasible and still miss its cost target, its positioning, or its channel. Launch Lab is built to surface those conflicts before they harden into expensive commitments.
Product Opportunity Assessment
Tell us what your customers need, what advantage the business already has, and what you want the product to accomplish. The first decision is whether the opportunity deserves deeper work.